SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K12B

8-K12B

Other
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML

Data provided by Kaleidoscope.